IRWD icon

Ironwood Pharmaceuticals

239 hedge funds and large institutions have $2.02B invested in Ironwood Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 76 increasing their positions, 78 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership:

more funds holding

Funds holding:

3% less repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 78

3% less capital invested

Capital invested by funds: $2.09B → $2.02B (-$72.4M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
239
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$876K
Puts
$231K
Net Calls
Net Calls Change

Top Buyers

1 +$142M
2 +$31.9M
3 +$29.9M
4
Renaissance Technologies
Renaissance Technologies
New York
+$26.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$13M

Top Sellers

1 -$71.7M
2 -$29.8M
3 -$18.7M
4
Norges Bank
Norges Bank
Norway
-$18.6M
5
Citadel Advisors
Citadel Advisors
Florida
-$10.5M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$310M
2
$189M
3
$172M
4
$167M
5
$134M
6
$126M
7
$86.2M
8
$62.4M
9
$56.5M
10
$51M
11
$39.7M
12
$35.5M
13
$30.2M
14
$29.7M
15
$26.7M
16
$25.9M
17
$24.3M
18
$19.2M
19
$18.9M
20
$18.8M
21
$17.2M
22
$16.6M
23
$15M
24
$14.2M
25
$14M